Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today reported financial results for the quarter ended June 30, 2014.
Management Commentary
“Anika made continued progress toward meeting its business goals and delivered solid financial results in the second quarter,” said Charles H. Sherwood, Ph.D., President and Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
